FEATURES: ORIGINAL INVESTIGATIONCurrent Available Cellular and Tissue-Based Products for Treatment of Skin DefectsLiu, Yukun MD; Panayi, Adriana C. MD; Bayer, Lauren R. PA-C; Orgill, Dennis P. MD, PhD Author Information At Brigham and Women’s Hospital in Boston, Massachusetts, Yukun Liu, MD, was a Research Fellow at the time this manuscript was written; Adriana C. Panayi, MD, is a Research Fellow; Lauren R. Bayer, PA-C, is Clinical Director of the Wound Care Center; and Dennis P. Orgill MD, PhD is Director of the Wound Care Center, Department of Surgery, Brigham and Women’s Hospital; and Professor of Surgery, Harvard Medical School. Acknowledgment: Dr Orgill is a consultant and/or receives research funding from Integra LifeSciences Corporation, the Musculoskeletal Research Foundation, Geistlich Corporation, Acell Corporation, and Professional Education and Research Incorporated. The authors have disclosed no other financial relationships related to this article. Submitted May 18, 2018; accepted June 29, 2018. Advances in Skin & Wound Care: January 2019 - Volume 32 - Issue 1 - p 19-25 doi: 10.1097/01.ASW.0000547412.54135.b7 Buy Metrics Abstract The occurrence of diabetic foot ulcers and venous leg ulcers is increasing because of aging population trends as well as increases in the number of people with diabetes and obesity. New technologies have been developed to treat these conditions, whereas other technologies previously designed for burns and traumatic wounds have been adapted. This article reviews the development of selected skin replacement technologies, particularly cellular and tissue-based products, highlighting their effectiveness on diabetic foot ulcers, venous leg ulcers, and burns. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.